-67%

est. 2Y upside i

HealthcareSeries C

Rank

#3358

Sector

Enterprise Systems (Healthcare)

Est. Liquidity

~3Y

Data Quality

Data: Low

The equity opportunity in WellSky (formerly ClearCare) presents moderate upside but comes with higher risk, primarily due to its private equity ownership and a severe preference stack.

Last updated: March 10, 2026

Bull (30%)+75%

WellSky successfully integrates its numerous acquisitions, including ClearCare (now WellSky Personal Care), and achieves strong organic growth, pushing revenue well past $1 billion. A favorable market for healthcare IT leads to an IPO or acquisition at a high multiple (e.g., 8-10x revenue), resulting in an enterprise valuation of $9-10 billion. This significantly clears the substantial liquidation preferences, providing a strong return for common shareholders.

Base (50%)+10%

WellSky continues its steady growth, reaching approximately $1 billion in revenue, and successfully maintains its market position in post-acute and home care. An exit (IPO or acquisition) occurs at a moderate multiple (e.g., 6-7x revenue), valuing the company around $6-7 billion. This valuation just clears the significant liquidation preferences, resulting in a modest return for common shareholders.

Bear (20%)-50%

WellSky faces challenges with M&A integration, increased competition from established players like Epic expanding into post-acute care, or a downturn in the healthcare IT market. The company's growth slows, and an exit valuation (e.g., 4-5x revenue, around $4-5 billion) fails to adequately clear the substantial liquidation preferences, leading to a significant loss or complete wipeout of value for common shareholders.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

WellSky has raised approximately $6.72 billion in funding, while its last known valuation was $3 billion in July 2020. This means investors hold significant liquidation preferences, and common shareholders would likely receive little to nothing unless the company exits at a valuation substantially exceeding $6.72 billion.

Dilution Risk

high

As a private equity-backed company with an active M&A strategy, WellSky may undertake further capital raises or debt financing, which could dilute common equity holders.

Secondary Liquidity

none

As a private equity-backed company, secondary markets for common stock are typically non-existent or very limited, offering no easy path to liquidity for employees.

View all 4 open roles at ClearCare →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on ClearCare's data — designed to show you've done your homework.

  • 1

    “Given WellSky's aggressive M&A strategy, how do you ensure successful integration of acquired companies like ClearCare/Personal Care into the broader platform, especially maintaining product quality and customer satisfaction?”

  • 2

    “With WellSky's significant revenue scale (~$800M+ and growing) and focus on post-acute care, what are the key strategies for achieving the projected $1B+ revenue target and expanding market share against competitors like Homecare Homebase and Axxess?”

  • 3

    “WellSky has substantial private equity backing. How does the company envision a liquidity event (e.g., IPO or further acquisition) over the next 2-4 years, and how are employee equity grants structured to ensure meaningful upside for common shareholders given the significant liquidation preferences?”

Community

Valuation Sentiment

Our model estimates -67% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.